Correlation Between NewAmsterdam Pharma and Gain Therapeutics

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Gain Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Gain Therapeutics.

Diversification Opportunities for NewAmsterdam Pharma and Gain Therapeutics

-0.3

Correlation Coefficient

NewAmsterdam Pharma  Gain Therapeutics

Very good diversification

The 3 months correlation between NewAmsterdam and Gain is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Gain Therapeutics go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Gain Therapeutics

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Gain Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 1.84 times less risky than Gain Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Gain Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  218.00  in Gain Therapeutics on December 30, 2024 and sell it today you would lose (29.00) from holding Gain Therapeutics or give up 13.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Gain Therapeutics

NewAmsterdam Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Gain Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Gain Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Gain Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with NewAmsterdam Pharma and Gain Therapeutics

The main advantage of trading using opposite NewAmsterdam Pharma and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.

The idea behind NewAmsterdam Pharma and Gain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.